School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, 4072, Australia.
Org Biomol Chem. 2022 Sep 21;20(36):7316-7324. doi: 10.1039/d2ob01307j.
Sterol 14α-demethylases (CYP51s) are a ubiquitous superfamily of cytochrome P450 enzymes that play an essential role in sterol biosynthesis. As fungal CYP51s are the target of azole-based antifungal agents, which are facing the problem of increasing resistance, the substrate specificity of this enzyme subclass has recently garnered significant attention. Herein we report the first chemical synthesis of the final endogenous substrate of this enzyme class, obtusifoliol, in 1.3% yield across ten steps from a commercially available lanosterol mixture. Intermediates along this pathway provide a basis for further derivatisation of the sterol skeleton and future investigation into CYP51 inhibition to overcome pathogens' azole resistance.
甾醇 14α-脱甲基酶(CYP51)是细胞色素 P450 酶的一个普遍存在的超家族,在甾醇生物合成中起着至关重要的作用。由于真菌 CYP51 是唑类抗真菌药物的靶标,而这些药物正面临着耐药性不断增加的问题,因此该酶亚类的底物特异性最近受到了广泛关注。在此,我们报告了该酶类的最终内源性底物 obtusifoliol 的首次化学合成,从商业可得的羊毛甾醇混合物出发,经 10 步反应以 1.3%的总收率得到 obtusifoliol。该途径中的中间体为甾醇骨架的进一步衍生化以及未来研究克服病原体唑类耐药性的 CYP51 抑制作用提供了基础。